PeptideDB

Pemirolast potassium (TWT-8152; BMY 26517) 100299-08-9

Pemirolast potassium (TWT-8152; BMY 26517) 100299-08-9

CAS No.: 100299-08-9

Pemirolast potassium (formerly TWT 8152; BMY 26517; TWT-8152; BMY-26517; Alegysal and Alamast), the potassium salt of Pe
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Pemirolast potassium (formerly TWT 8152; BMY 26517; TWT-8152; BMY-26517; Alegysal and Alamast), the potassium salt of Pemirolast, is a poten and orally bioactive histamine H1 antagonist and mast cell stabilizer with potential antiallergic effects. For the treatment of asthma, a nonbronchodilator antiallergy medication candidate is being researched.



Physicochemical Properties


Molecular Formula C10H7KN6O
Molecular Weight 266.3
Exact Mass 266.031
Elemental Analysis C, 45.10; H, 2.65; K, 14.68; N, 31.56; O, 6.01
CAS # 100299-08-9
Related CAS # Pemirolast; 69372-19-6
PubChem CID 443866
Appearance Light yellow to green yellow solid powder
Boiling Point 454.8ºC at 760mmHg
Melting Point 310-311ºC (dec.)
Flash Point 228.9ºC
Vapour Pressure 1.85E-08mmHg at 25°C
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 6
Rotatable Bond Count 1
Heavy Atom Count 18
Complexity 495
Defined Atom Stereocenter Count 0
SMILES

O=C1C(C2=N[N-]N=N2)=CN=C3N1C=CC=C3C.[K+]

InChi Key NMMVKSMGBDRONO-UHFFFAOYSA-N
InChi Code

InChI=1S/C10H7N6O.K/c1-6-3-2-4-16-9(6)11-5-7(10(16)17)8-12-14-15-13-8;/h2-5H,1H3;/q-1;+1
Chemical Name

potassium;9-methyl-3-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)pyrido[1,2-a]pyrimidin-4-one
Synonyms

TWT-8152; BMY 26517; TWT 8152; BMY 26517; TWT8152; BMY 26517; Pemirolast; Pemirolast potassium. trade name: Alegysal and Alamast.
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Note: Please store this product in a sealed and protected environment, avoid exposure to moisture.
Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


Targets Histamine H1 receptor
ln Vitro

In vitro activity: Pemirolast potassium (BMY 26517) is a brand-new oral nonbronchodilator antiallergy drug that's currently being tested for use in treating asthma. In addition to being shown to inhibit the release of peptides such as substance P, [2] neurokinin (NK) A, and calcitonin gene-related peptide (CGRP) from sensory nerves, pemirolast potassium (BMY 26517) also inhibits the release of chemical mediators from tissue mast cells.[3] In order to prevent pulmonary hypersensitivity reactions to medications like paclitaxel, pemirolast potassium is used as a treatment for allergic conjunctivitis.[4]

ln Vivo
Pemirolast potassium (BMY 26517) inhibits the release of substance P in rats, thereby reducing their intake of kaolin. [2] Pemirolast inhibits the release of sensory neuropeptides in rats, thereby potently attenuating hypersensitivity reactions to paclitaxel. [3]
Animal Protocol

Rats
References

[1]. Ann Allergy . 1992 Jun;68(6):488-91.

[2]. Eur J Pharmacol . 2011 Jul 1;661(1-3):57-62.

[3]. Neuropharmacology . 2004 May;46(6):888-94.

[4]. J Ocul Pharmacol Ther . 2002 Oct;18(5):475-88.

Additional Infomation Pemirolast Potassium is the potassium salt form of pemirolast, a pyrimidinone derivative with antiallergic property. Pemirolast potassium exerts its action by blocking the antigen-mediated calcium ion influx into mast cells. This prevents mast cell degranulation, resulting in mast cell stabilization and inhibition of the release of inflammatory mediators, histamine and leukotrienes, which are involved in the allergic process. Pemirolast potassium also prevents inflammatory mediator release from eosinophils.

Solubility Data


Solubility (In Vitro)
DMSO: <1 mg/mL
Water: ~53 mg/mL (~199.0 mM)
Ethanol: <1 mg/mL
Solubility (In Vivo) Solubility in Formulation 1: 100 mg/mL (375.52 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 3.7552 mL 18.7758 mL 37.5516 mL
5 mM 0.7510 mL 3.7552 mL 7.5103 mL
10 mM 0.3755 mL 1.8776 mL 3.7552 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.